- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
ACO2 Antibody (C-term) Blocking PeptideSynthetic peptide
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| BP7561b | 0.1 mg 400 ul | In Stock | $ 45.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
ACO2 Antibody (C-term) Blocking Peptide - Product info | |
| Primary Accession | Q99798 |
| Clone Names | 80102110 |
| Calculated MW | 85425 Da |
ACO2 Antibody (C-term) Blocking Peptide - Additional info | |
| Gene ID 50 | |
| Target/Specificity The synthetic peptide sequence used to generate the antibody AP7561b was selected from the C-term region of human ACO2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. | |
| Format Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. | |
| Precautions This product is for research use only. Not for use in diagnostic or therapeutic procedures. | |
ACO2 Antibody (C-term) Blocking Peptide - Protein Information | |
| Name ACO2 | |
| Function Catalyzes the isomerization of citrate to isocitrate via cis-aconitate (By similarity) | |
| Cellular Location Mitochondrion (By similarity). | |
ACO2 Antibody (C-term) Blocking Peptide - Related products
AP1936a: ACO2 Antibody (N-term)
AP1936c: ACO2 Antibody (Center)
AP7561b: ACO2 Antibody (C-term)
AP7561c: ACO2 Antibody (Center)
AP7561d: ACO2 Antibody (C-term)
BP1936a: ACO2 Antibody (N-term) Blocking Peptide
BP1936c: ACO2 Antibody (Center) Blocking Peptide
BP7561b: ACO2 Antibody (C-term) Blocking Peptide
ACO2 Antibody (C-term) Blocking Peptide - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
ACO2 belongs to the aconitase/IPM isomerase family. It is an enzyme that catalyzes the interconversion of citrate to isocitrate via cis-aconitate in the second step of the TCA cycle. It was found to be one of the mitochondrial matrix proteins that are preferentially degraded by the serine protease 15(PRSS15), also known as Lon protease, after oxidative modification.
REFERENCES
Yu,Z.,Prostate 66 (10), 1061-1069 (2006)Tsui,K.H.,Asian J. Androl. 8 (3), 307-315 (2006)Ahmed,M.,J. Proteome Res. 4 (3), 931-940 (2005)
